SCHEMBL2637520

SCHEMBL2637520

O=C(O)c1ccccc1NC(=O)c1c(=O)[nH]n2c(=O)cc(-c3ccccc3)[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
PKM P14618 1/20 0.43
GFER P55789 1/20 0.41
SUCNR1 Q9BXA5 1/20 0.41
CA12 O43570 3/20 0.40
CA7 P43166 3/20 0.40
CA4 P22748 2/20 0.40
CA1 P00915 1/20 0.40
EGFR P00533 1/20 0.39
SRC P12931 1/20 0.39
NHERF1 O14745 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ERCC1 P07992 1/20 0.39
FEN1 P39748 1/20 0.39
ERCC4 Q92889 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2638043 0.86 MAPK10 (0.45) DHODHMEN1KMT2ANPC1RAB9A
SCHEMBL2637918 0.83 KMT2A (0.41) DHODHMEN1KMT2APKMEGFR
SCHEMBL2637350 0.83 ERCC1 (0.48) DHODHMEN1KMT2APKMKDM4E
SCHEMBL2637592 0.82 MEN1 (0.45) MEN1KMT2AEGFRSRCNPC1
SCHEMBL2637908 0.81 NPC1 (0.45) MEN1KMT2AKDM4ENPC1RAB9A
SCHEMBL2640983 0.80 ALDH1A1 (0.47) MEN1KMT2AKDM4ENPC1RAB9A
SCHEMBL2637445 0.80 NPC1 (0.38) DHODHMEN1KMT2APKMKDM4E
SCHEMBL2637500 0.79 ALDH1A1 (0.39) DHODHMEN1KMT2AKDM4EERCC1
SCHEMBL2637516 0.79 MEN1 (0.48) MEN1KMT2AEGFRSRCKDM4E
SCHEMBL2637180 0.79 CGAS (0.46) MEN1KMT2APKMKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed